Your browser doesn't support javascript.
loading
How to Provide the Needed Protection from COVID-19 to Patients with Hematologic Malignancies.
Ribas, Antoni; Dhodapkar, Madhav V; Campbell, Katie M; Davies, Faith E; Gore, Steven D; Levy, Ronald; Greenberger, Lee M.
Afiliação
  • Ribas A; Department of Medicine and Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California. aribas@mednet.ucla.edu.
  • Dhodapkar MV; Department of Hematology and Medical Oncology at the Winship Cancer Institute of Emory University, Atlanta, Georgia.
  • Campbell KM; Department of Medicine and Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California.
  • Davies FE; Department of Medicine and Perlmutter Cancer Center, New York University, New York, New York.
  • Gore SD; AACR Hematologic Malignancies Task Force, Philadelphia, Pennsylvania.
  • Levy R; AACR Hematologic Malignancies Task Force, Philadelphia, Pennsylvania.
  • Greenberger LM; Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Blood Cancer Discov ; 2(6): 562-567, 2021 11.
Article em En | MEDLINE | ID: mdl-34778796
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Hematológicas / COVID-19 Limite: Adult / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Hematológicas / COVID-19 Limite: Adult / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article